Treating Multiple Sclerosis Why You Shouldn t Stop Taking Your Meds

Treating Multiple Sclerosis Why You Shouldn t Stop Taking Your Meds

Treating Multiple Sclerosis: Why You Shouldn’t Stop Taking Your Meds Health ConditionsFeaturedBreast CancerIBD MigraineMultiple Sclerosis (MS)Rheumatoid ArthritisType 2 DiabetesSponsored TopicsArticlesAcid RefluxADHDAllergiesAlzheimer's & DementiaBipolar DisorderCancerCrohn's DiseaseChronic PainCold & FluCOPDDepressionFibromyalgiaHeart DiseaseHigh CholesterolHIVHypertensionIPFOsteoarthritisPsoriasisSkin Disorders and CareSTDsDiscoverWellness TopicsNutritionFitnessSkin CareSexual HealthWomen's HealthMental HealthSleepOriginal SeriesFresh Food FastDiagnosis DiariesYou’re Not AlonePresent TenseVideo SeriesYouth in FocusHealthy HarvestNo More SilenceFuture of HealthPlanHealth ChallengesMindful EatingSugar SavvyMove Your BodyGut HealthMood FoodsAlign Your SpineFind CarePrimary CareMental HealthOB-GYNDermatologistsNeurologistsCardiologistsOrthopedistsLifestyle QuizzesWeight ManagementAm I Depressed? A Quiz for TeensAre You a Workaholic?How Well Do You Sleep?Tools & ResourcesHealth NewsFind a DietFind Healthy SnacksDrugs A-ZHealth A-ZConnectFind Your Bezzy CommunityBreast CancerInflammatory Bowel DiseasePsoriatic ArthritisMigraineMultiple SclerosisPsoriasisFollow us on social mediaShopProducts by ConditionInsomniaStress ReliefBack PainNeck PainSleep ApneaHot SleepersAllergiesPain ReliefProduct ReviewsVitamins & SupplementsSleepMental HealthNutritionAt-Home TestingCBDMen’s HealthWomen’s HealthHealth ConditionsDiscoverPlanConnectShopSubscribe

6 Reasons to Take a DMT for MS Even When You Feel Fine

Medically reviewed by Susan W. Lee, DO — By Stephanie Watson on October 11, 2022Multiple sclerosis (MS) isn’t curable, but taking disease-modifying therapies (DMTs) can help reduce the number of MS relapses and slow progression of the disease. Even so, the decision to take a DMT isn’t always easy, especially soon after your diagnosis. Some people worry about taking medications that can cause side effects when they don’t have any MS symptoms. Plus, MS drugs are expensive. For these and other reasons, one study found that up to 40% of participants with MS stopped taking DMTs within 1 year after starting them. It’s important to weigh the risks against the benefits of taking any medication. Having a conversation with your doctor about how these medications may impact you can help you make the right treatment decisions moving forward. There are a few good reasons to stay on your MS treatment. Here are six of them.

Fewer relapses

Up to 90% of people living with MS have the relapsing-remitting form of the disease. This comes with periods where old symptoms flare up or new symptoms like fatigue, vision changes, and weakness develop. These symptom attacks are followed by symptom-free periods of full or partial recovery, called remission. Taking DMTs is one way to reduce the number of MS relapses you have. One study found that people who stayed on their medication were 42% less likely to relapse than those who didn’t take their medication as prescribed.

Less severe relapses

Relapses range from mild symptoms that are barely noticeable to severe symptoms that can disrupt your daily life. You might still experience relapses while taking DMTs, but they’re likely to be less severe. That means that symptoms will be milder and less disruptive to your life.

Slower MS damage

In MS, the immune system attacks myelin, the insulation that wraps around and protects nerve cells. Without this protective coating, nerve cells become damaged. As a result, nerve signals can’t travel as they normally should from your brain and spinal cord to the rest of your body. MS is a progressive disease. Damage to the brain and spinal cord builds up over time, even when you don’t have active symptoms. DMTs put the brakes on this damage and slow the progression of the disease. These drugs work by reducing the inflammation that leads to nervous system damage. As evidence, people who take DMTs have fewer lesions in their brain and spinal cord on magnetic resonance imaging (MRI) scans.

Less need for hospital stays

About 1 in 4 people with MS need to go to the hospital each year, a rate much higher than in the overall population. Relapses are one of the most common reasons for these hospital visits. Because DMTs slow MS and its damage, they can help keep you out of the hospital. Research has found that people with MS who take their medications as prescribed are less likely to be hospitalized than those who stop taking DMTs. The risk of a hospital stay is up to 44% lower in people who are on DMTs, depending on the type of medication they take.

Lower risk for disability

Starting treatment early and staying on it could help prevent issues with mobility. People who have a higher number of relapses and more severe symptoms, especially in the first 2 years after diagnosis, are more likely to have worse MS. A 2021 study analyzed data from a registry of more than 14,000 people with MS. The researchers found that staying on DMT treatment reduced disability by up to 44% and lowered the odds of needing a walking aid like a cane or walker by 67%. Another study showed that people taking DMTs recover more fully after a relapse. Making a full recovery after each relapse might reduce your risk of MS-related disability in the future.

Cost savings

DMTs are expensive medications. In 2022, the average cost per year for a brand-name drug was nearly $94,000, according to the National MS Society. Even with good health insurance, you may have to cover copayments and other out-of-pocket costs. Even so, there’s a cost advantage to staying on your medication. Taking a DMT can prevent the types of severe symptoms and disability that might otherwise lead to a costly hospital stay. According to a 2022 study, people who took their medication regularly for an entire year spent more than $8,500 less in medical costs than those who weren’t consistent about taking their DMT. After 2 years on DMTs, the savings nearly doubled to more than $16,000 for those who stuck to their treatment regimen.

The takeaway

There are reasons to approach DMTs cautiously after an MS diagnosis. These medications can cause side effects, which might worry you — especially if you don’t have any symptoms from MS. Yet there are also many reasons to take them, including lower relapse rates, less severe relapses, and less disability in the long run. Discuss any concerns about your medication with the doctor who treats your MS. There are ways to manage treatment costs and side effects. Many different DMTs are available today, and there’s a good chance you can find one that’s both affordable and tolerable. Last medically reviewed on October 11, 2022

How we vetted this article

SourcesHistoryHealthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.Affordability and access to MS medications. (n.d.).
nationalmssociety.org/Get-Involved/Advocate-for-Change/Current-Advocacy-Issues/Affordability-of-and-Access-to-MS-MedicationsBurks J, et al. (2017). Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis.
ncbi.nlm.nih.gov/pmc/articles/PMC5417677/Carlson A, et al. (2022). Healthcare utilization in multiple sclerosis: impact of disease modifying therapies and comorbidities.
ncbi.nlm.nih.gov/pmc/articles/PMC8957556/Disease-modifying therapies. (n.d.).
mssociety.ca/managing-ms/treatments/medications/disease-modifying-therapies-dmtsFreeman L, et al. (2021). Evaluating treatment patterns, relapses, healthcare resource utilization, and costs associated with disease-modifying treatments for multiple sclerosis in DMT-naïve patients.
ncbi.nlm.nih.gov/pmc/articles/PMC7837567/Kalincik T, et al. (2021). Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years.
ncbi.nlm.nih.gov/pmc/articles/PMC7884998/Lynd LD, et al. (2018). Perspectives of patients with multiple sclerosis on drug treatment.
ncbi.nlm.nih.gov/pmc/articles/PMC6295877/Maia C, et al. (2019). All-cause hospitalizations in multiple sclerosis patients.
neurologia.com/articulo/2018281/engManaging relapses. (n.d.).
nationalmssociety.org/Treating-MS/Managing-RelapsesPardo G, et al. (2022) The association between persistence and adherence to disease-modifying therapies and healthcare resource utilization and costs in patients with multiple sclerosis.
jheor.org/article/33288-the-association-between-persistence-and-adherence-to-disease-modifying-therapies-and-healthcare-resource-utilization-and-costs-in-patients-with-multipQuantifying the effect of the high cost of DMTs. (2019).
nms2cdn.azureedge.net/cmssite/nationalmssociety/media/msnationalfiles/advocacy/nmss-research-report-full-access-to-ms-medications.pdfRelapsing remitting MS (RRMS). (n.d.).
mssociety.org.uk/about-ms/types-of-ms/relapsing-remitting-msRelapsing-remitting MS (RRMS). (n.d.).
nationalmssociety.org/What-is-MS/Types-of-MS/Relapsing-remitting-MSSotiropoulos MG, et al. (2021). Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.
ncbi.nlm.nih.gov/pmc/articles/PMC8165535/pdf/10.1177_20552173211015503.pdfThe importance of long-term treatment for multiple sclerosis. (n.d.).
mymsaa.org/ms-information/overview/long-term-treatment/Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Current Version Oct 11, 2022 By Stephanie Watson Edited By Kerry Weiss Medically Reviewed By Susan W. Lee, DO Copy Edited By Stassi Myer - CE Share this articleMedically reviewed by Susan W. Lee, DO — By Stephanie Watson on October 11, 2022

More in Navigating Life with Relapsing Remitting MS

Portraits of MS: What I Wish I Had KnownMS Perspectives: My Diagnosis StoryMy First Year with MSMultiple Sclerosis Nausea ExplainedView all

Read this next

Portraits of MS: What I Wish I Had Known Real patients offer advice and encouragement to those recently diagnosed with multiple sclerosis.READ MOREMS Perspectives: My Diagnosis Story Everyone with multiple sclerosis has a different diagnosis story. Read how three people with MS found out about their condition and how they chose to…READ MOREMy First Year with MSMedically reviewed by Seunggu Han, M.D. Multiple sclerosis symptoms can be unsettling and also unpredictable. Learn what symptoms three MS patients experienced during their first year and…READ MOREMultiple Sclerosis Nausea ExplainedMedically reviewed by Seunggu Han, M.D. Though not the most common multiple sclerosis symptom, nausea is possible. It can be a direct symptom, or result from other symptoms or medication…READ MORE
Share:
0 comments

Comments (0)

Leave a Comment

Minimum 10 characters required

* All fields are required. Comments are moderated before appearing.

No comments yet. Be the first to comment!